Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 29,420 | 17,585 | 21,258 | 10,985 | 115 |
| Gross Profit | 29,420 | 17,585 | 21,258 | 10,985 | 115 |
| Operating Expenses | 50,354 | 33,092 | 48,716 | 44,093 | 33,098 |
| Operating Income | -20,934 | -15,507 | -27,458 | -33,108 | -32,983 |
| Other Income | -11,243 | -9,652 | 3,505 | 5,940 | 4,296 |
| Pre-tax Income | -32,177 | -25,159 | -23,953 | -27,168 | -28,688 |
| Net Income Continuous | -32,177 | -25,159 | -23,953 | -27,168 | -28,688 |
| Net Income | $-32,177 | $-25,159 | $-23,953 | $-27,168 | $-28,688 |
| EPS Basic Total Ops | -1.74 | -1.62 | -2.04 | -3.00 | -3.24 |
| EPS Basic Continuous Ops | -1.74 | -1.62 | -2.07 | -3.02 | -3.27 |
| EPS Diluted Total Ops | -1.74 | -1.62 | -2.04 | -3.00 | -3.24 |
| EPS Diluted Continuous Ops | -1.74 | -1.62 | -2.07 | -3.02 | -3.27 |
| EBITDA(a) | $-19,471 | $-14,128 | $-25,989 | $-31,094 | $-30,893 |